-The Hindu Business Line   The general tendency among Indian policy makers currently is to blame international price movements for the rise in prices of essential food items in India. The extent to which this claim is valid is assessed by examining the specific case of wheat. It is no secret that Indian food prices are increasingly affected by international prices. Ever since 2002, when all quantitative restrictions on Indian imports of agricultural...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...

-The Hindu     Well-known feminist Kamla Bhasin says that Indian men will have to change, not to support women but to save themselves from being brutalised by centuries of exposure to patriarchy. "Mian, aap mein kuch kami hai" (Gentleman, there is something wrong with you)." Some months ago, when Kamla Bhasin, well-known feminist from Delhi, came up with this retort to Aamir Khan on his headline-grabbing tele-show Satyameva Jayate on saying that he...

KEY TRENDS   • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8   • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...

The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...